Luye Pharma Group Ltd. (2186.HK) HKSE

3.35

+0.08(+2.45%)

Updated at October 20 09:29AM

Currency In HKD

Valuation

Market Cap7.67B
Enterprise Value13.05B
P/E Ratio28.42
PEG Ratio-3.41
Price/Sales Ratio1.83
Price/Book Ratio0.77
Enterprise/Revenue2.63
Enterprise/EBITDA9.38

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin0.06
Operating Margin0.18

Management Effectiveness

Return On Assets0.01
Return On Equity0.03

Income Statement

Revenue6.06B
Revenue/Share1.64
Gross Profit4.04B
EBITDA1.79B
Net Income471.89M
Diluted EPS0.13

Balance Sheet

Total Cash8.83B
Total Cash/Share1.91
Total Debt11.87B
Total Debt/Equity0.81
Current Ratio1.31
Book Value Per Share4.4

Price History

52-Week Change5.83
52-Week High4.49
52-Week Low1.67
Moving Average 50 Days3.62
Moving Average 200 Days2.85

Statistics

Average Volume66.01M
Shares Outstanding3.76B
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A